Lilly's Weight-Loss Drug Wallops Novo's In Head-To-Head Study; Novo Stock Dives

Novo Nordisk stock skidded Tuesday after Eli Lilly's weight-loss drug outperformed Novo's rival medication in a first-of-its-kind study. The post Lilly's…

Related Keywords

Eli Lilly ,Novo Nordisk ,Weight Loss Drug Wallops Novo ,Head To Study ,Novo Stock Dives ,News ,Ggregator ,Reaking News ,Uration ,Media ,